Skip to Main Content

Author Details

Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
1997
95
32
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35979721Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes.Haematologica2023
37961434Impact of Memory T Cells on SARS-COV-2 Vaccine Response in Hematopoietic Stem Cell Transplant.bioRxiv2023
37704469Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).Blood Rev2023
37742191ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m<sup>6</sup>A modification-mediated RNA stability control.Cell Rep2023
37312418Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.Small Methods2023
36752625Editorial: Molecular advances make the day in myeloid diseases.Curr Opin Hematol2023
36437356Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy.Leukemia2023
36934059Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).Blood Rev2023
36602939Is it the time to integrate novel sequencing technologies into clinical practice?Curr Opin Hematol2023
36823353High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq.Nat Biotechnol2023
36260702An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.Blood Adv2023
34611663Inflammasome activation in infected macrophages drives COVID-19 pathology.bioRxiv2022
35378748Spatial-CITE-seq: spatially resolved high-plex protein and whole transcriptome co-mapping.Res Sq2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35372085The Coming of Age of Preclinical Models of MDS.Front Oncol2022
35626039Are We Moving the Needle for Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia?Cancers (Basel)2022
35483404Inflammasome activation in infected macrophages drives COVID-19 pathology.Nature2022
36516754Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis.Cell Rep2022
36595959Deconvolution of in vivo protein-RNA contacts using fractionated eCLIP-seq.STAR Protoc2022
36109149Widespread association of the Argonaute protein AGO2 with meiotic chromatin suggests a distinct nuclear function in mammalian male reproduction.Genome Res2022
36266326Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.Leukemia2022
35926182Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.Blood Cancer Discov2022
36093346Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity.bioRxiv2022
35978191Spatial profiling of chromatin accessibility in mouse and human tissues.Nature2022
35132421A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste.medRxiv2022
34921308A humanized mouse model of chronic COVID-19.Nat Biotechnol2022
35273342In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.Leukemia2022
35303483Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.Mol Cell2022
35296003<i>DNMT3A</i> R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.Front Oncol2022
33394725Editorial: Do not lose focus on myeloid biology in the era of COVID-19.Curr Opin Hematol2021
33758831A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options.Res Sq2021
33674488Combined liver-cytokine humanization comes to the rescue of circulating human red blood cells.Science2021
33778776Transcriptome-wide quantification of double-stranded RNAs in live mouse tissues by dsRIP-Seq.STAR Protoc2021
33635335A neutrophil activation signature predicts critical illness and mortality in COVID-19.Blood Adv2021
33551344Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies.Clin Lymphoma Myeloma Leuk2021
34589432Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases.Front Oncol2021
33214651Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.Nat Rev Cardiol2021
32437909Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.Exp Hematol2020
33777659The role of RNA epigenetic modification in normal and malignant hematopoiesis.Curr Stem Cell Rep2020
31926939Humanized mice as preclinical models for myeloid malignancies.Biochem Pharmacol2020
31776933Functional Analysis of Human Hematopoietic Stem Cells In Vivo in Humanized Mice.Methods Mol Biol2020
31883804The minimal that kills: Why defining and targeting measurable residual disease is the "Sine Qua Non" for further progress in management of acute myeloid leukemia.Blood Rev2020
33282193Circulating markers of angiogenesis and endotheliopathy in COVID-19.Pulm Circ2020
33188776High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue.Cell2020
32637968Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19.medRxiv2020
32908988A neutrophil activation signature predicts critical illness and mortality in COVID-19.medRxiv2020
32619411Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.Lancet Haematol2020
32640014Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms.Blood2020
32497523m[6]A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development.Immunity2020
30664659A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies.Nat Commun2019
  • 1 - 50 of 95

Recommended Authors

and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 1
Inner Mongolia University
Career Start Year 2010
Number of shared co-authors 1
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Huntsman Cancer Institute, University of Utah
Career Start Year 2009
Number of shared co-authors 3
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 2
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 5
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
University of Washington
Career Start Year 2002
Number of shared co-authors 4
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 9
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 1
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 1
University of California Irvine
Career Start Year 1998
Number of shared co-authors 0
University of Pavia & S. Matteo Hospital
Career Start Year 1997
Number of shared co-authors 8
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 5
The University of Chicago
Career Start Year 1994
Number of shared co-authors 8
Kinderklinik und Kinderpoliklinik der Ludwig-Maximilians-Universitat Munchen
Career Start Year 1993
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 5
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 5
Kyoto University
Career Start Year 1993
Number of shared co-authors 5
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 5
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 0
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 0
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 0
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Vanderbilt University
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Yale School of Medicine
Co-authored papers 13
Yale Comprehensive Cancer Center, Yale University School of Medicine
Co-authored papers 13
Yale University School of Medicine
Co-authored papers 6
Yale School of Medicine
Co-authored papers 6
Yale University School of Medicine
Co-authored papers 6
Yale University
Co-authored papers 5
Moores Cancer Center, university of california san diego
Co-authored papers 5
Institute of Pathogens and Vectors, Dali University
Co-authored papers 5
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 5
Yale Cardiovascular Research Center, Yale University School of Medicine
Co-authored papers 5
Yale School of Medicine
Co-authored papers 4
Yale University School of Medicine
Co-authored papers 4
Yale University
Co-authored papers 4
Yale Cancer Center and Yale School of Medicine
Co-authored papers 4
Institute of Medicine, University of Tsukuba
Co-authored papers 4
Novartis Institutes for BioMedical Research
Co-authored papers 4
and Blood Institute, National Institutes of Health
Co-authored papers 4
Yale School of Medicine, Yale School of Public Health
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
The Ohio State University
Co-authored papers 4
Yale University School of Medicine
Co-authored papers 4
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 4
Co-authored papers 4
Yale School of Medicine
Co-authored papers 3
Yale School of Medicine, Yale University
Co-authored papers 3
Yale University
Co-authored papers 3
The Ohio State University Wexner Medical Center
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale University
Co-authored papers 2
Yale University
Co-authored papers 2